EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Management of the Axilla for Early‐Stage Breast Cancer: A State‐Of‐The‐Art Review

Fausto Petrelli iD, Valerio Pavesi, Agostina De Stefani, Antonio Felici, Silvia Ruggiero, Silvia Seghezzi, Andrea Esposito, Fulvia Milena Cribiu', Paola Mercurio, Loredana Burgoa

ANZ Journal of Surgery · 25.06.2026

DOI: 10.1111/ans.70820 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ANZ Journal of Surgery, online erschienen am 25.06.2026. Verfasst von Fausto Petrelli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Unit, ASST Bergamo Ovest, Treviglio, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Axillary management in early‐stage breast cancer has shifted from routine clearance to selective, biology‐driven intervention. Advances in systemic therapy, imaging, and radiotherapy have reduced the need for axillary lymph node dissection (ALND), limiting morbidity without compromising oncologic outcomes.

Methods

This narrative review summarizes evidence supporting surgical de‐escalation, targeted axillary dissection (TAD), and regional nodal irradiation (RNI), drawing on randomized trials, prospective cohorts, and international guidelines.

Results

Randomized trials show that completion ALND can be safely omitted in patients with limited sentinel lymph node (SLN) involvement, with equivalent survival and lower lymphedema rates. Noninferiority studies indicate that SLN biopsy itself may be omitted in selected low‐risk patients with negative axillary imaging. In biopsy‐proven node‐positive disease treated with neoadjuvant therapy, TAD—retrieving the clipped node together with SLNs—reduces false‐negative rates to ≤ 5%, allowing omission of ALND in responders.

Conclusion

Axillary treatment has evolved toward individualized, minimally invasive strategies guided by tumor biology, treatment response, and patient priorities, requiring multidisciplinary decision‐making to optimize outcomes.

Autor:innen und Institutionen

  • Oncology Unit, ASST Bergamo Ovest, Treviglio, Italy.
  • Radiology Unit, ASST Bergamo Ovest, Treviglio, Italy.
  • Radiotherapy Unit, ASST Bergamo Ovest, Treviglio, Italy.
  • Breast Unit, ASST Bergamo Ovest, Treviglio, Italy.
  • Nuclear Medicine Unit, ASST Bergamo Ovest, Treviglio, Italy.
  • Pathology Unit, ASST Bergamo Ovest, Treviglio, Italy.

ORCID-Profile: Fausto Petrelli

Zitieren

APA

Petrelli, F., Pavesi, V., De Stefani, A., Felici, A., Ruggiero, S., Seghezzi, S., Esposito, A., Cribiu', F. M., Mercurio, P., & Burgoa, L. (2026). Management of the Axilla for Early‐Stage Breast Cancer: A State‐Of‐The‐Art Review. ANZ Journal of Surgery. https://doi.org/10.1111/ans.70820

Vancouver

Petrelli F, Pavesi V, De Stefani A, Felici A, Ruggiero S, Seghezzi S, et al. Management of the Axilla for Early‐Stage Breast Cancer: A State‐Of‐The‐Art Review. ANZ Journal of Surgery. 2026. doi:10.1111/ans.70820

BibTeX
@article{Petrelli2026,
  author = {Petrelli, Fausto and Pavesi, Valerio and De Stefani, Agostina and Felici, Antonio and Ruggiero, Silvia and Seghezzi, Silvia and Esposito, Andrea and Cribiu', Fulvia Milena and Mercurio, Paola and Burgoa, Loredana},
  title = {Management of the Axilla for Early‐Stage Breast Cancer: A State‐Of‐The‐Art Review},
  journal = {ANZ Journal of Surgery},
  year = {2026},
  doi = {10.1111/ans.70820}
}
Kostenlos starten →